337 related articles for article (PubMed ID: 19420258)
1. Direct control of peripheral lipid deposition by CNS GLP-1 receptor signaling is mediated by the sympathetic nervous system and blunted in diet-induced obesity.
Nogueiras R; Pérez-Tilve D; Veyrat-Durebex C; Morgan DA; Varela L; Haynes WG; Patterson JT; Disse E; Pfluger PT; López M; Woods SC; DiMarchi R; Diéguez C; Rahmouni K; Rohner-Jeanrenaud F; Tschöp MH
J Neurosci; 2009 May; 29(18):5916-25. PubMed ID: 19420258
[TBL] [Abstract][Full Text] [Related]
2. Cooperative role of the glucagon-like peptide-1 receptor and β3-adrenergic-mediated signalling on fat mass reduction through the downregulation of PKA/AKT/AMPK signalling in the adipose tissue and muscle of rats.
Decara J; Rivera P; Arrabal S; Vargas A; Serrano A; Pavón FJ; Dieguez C; Nogueiras R; Rodríguez de Fonseca F; Suárez J
Acta Physiol (Oxf); 2018 Apr; 222(4):e13008. PubMed ID: 29193738
[TBL] [Abstract][Full Text] [Related]
3. Direct control of brown adipose tissue thermogenesis by central nervous system glucagon-like peptide-1 receptor signaling.
Lockie SH; Heppner KM; Chaudhary N; Chabenne JR; Morgan DA; Veyrat-Durebex C; Ananthakrishnan G; Rohner-Jeanrenaud F; Drucker DJ; DiMarchi R; Rahmouni K; Oldfield BJ; Tschöp MH; Perez-Tilve D
Diabetes; 2012 Nov; 61(11):2753-62. PubMed ID: 22933116
[TBL] [Abstract][Full Text] [Related]
4. Hyperphagia and increased fat accumulation in two models of chronic CNS glucagon-like peptide-1 loss of function.
Barrera JG; Jones KR; Herman JP; D'Alessio DA; Woods SC; Seeley RJ
J Neurosci; 2011 Mar; 31(10):3904-13. PubMed ID: 21389245
[TBL] [Abstract][Full Text] [Related]
5. The central melanocortin system directly controls peripheral lipid metabolism.
Nogueiras R; Wiedmer P; Perez-Tilve D; Veyrat-Durebex C; Keogh JM; Sutton GM; Pfluger PT; Castaneda TR; Neschen S; Hofmann SM; Howles PN; Morgan DA; Benoit SC; Szanto I; Schrott B; Schürmann A; Joost HG; Hammond C; Hui DY; Woods SC; Rahmouni K; Butler AA; Farooqi IS; O'Rahilly S; Rohner-Jeanrenaud F; Tschöp MH
J Clin Invest; 2007 Nov; 117(11):3475-88. PubMed ID: 17885689
[TBL] [Abstract][Full Text] [Related]
6. Pharmacological targeting of glucagon and glucagon-like peptide 1 receptors has different effects on energy state and glucose homeostasis in diet-induced obese mice.
Gu W; Lloyd DJ; Chinookswong N; Komorowski R; Sivits G; Graham M; Winters KA; Yan H; Boros LG; Lindberg RA; Véniant MM
J Pharmacol Exp Ther; 2011 Jul; 338(1):70-81. PubMed ID: 21471191
[TBL] [Abstract][Full Text] [Related]
7. Oxyntomodulin and glucagon-like peptide-1 differentially regulate murine food intake and energy expenditure.
Baggio LL; Huang Q; Brown TJ; Drucker DJ
Gastroenterology; 2004 Aug; 127(2):546-58. PubMed ID: 15300587
[TBL] [Abstract][Full Text] [Related]
8. Neuronal and intracellular signaling pathways mediating GLP-1 energy balance and glycemic effects.
Hayes MR
Physiol Behav; 2012 Jun; 106(3):413-6. PubMed ID: 22366059
[TBL] [Abstract][Full Text] [Related]
9. EGLP-1 lowers body weight better than exendin-4 by reducing food intake and increasing basal energy expenditure in diet-induced obese mice.
Gao H; Zhao Q; Li K; Qin F; Yin X; Lu Z; Song Z; Wu Y; Shen Y; Pan Y; Jin L; Yanfeng Zhang
Exp Cell Res; 2021 Feb; 399(1):112454. PubMed ID: 33359447
[TBL] [Abstract][Full Text] [Related]
10. Central glucagon like peptide-1 delays solid gastric emptying via central CRF and peripheral sympathetic pathway in rats.
Nakade Y; Tsukamoto K; Pappas TN; Takahashi T
Brain Res; 2006 Sep; 1111(1):117-21. PubMed ID: 16884700
[TBL] [Abstract][Full Text] [Related]
11. Glucagon-like peptide (GLP)-2 action in the murine central nervous system is enhanced by elimination of GLP-1 receptor signaling.
Lovshin J; Estall J; Yusta B; Brown TJ; Drucker DJ
J Biol Chem; 2001 Jun; 276(24):21489-99. PubMed ID: 11262390
[TBL] [Abstract][Full Text] [Related]
12. Central pre-proglucagon derived peptides: opportunities for treatment of obesity.
Larsen PJ; Vrang N; Tang-Christensen M
Curr Pharm Des; 2003; 9(17):1373-82. PubMed ID: 12769729
[TBL] [Abstract][Full Text] [Related]
13. The glucose-dependent insulinotropic polypeptide (GIP) regulates body weight and food intake via CNS-GIPR signaling.
Zhang Q; Delessa CT; Augustin R; Bakhti M; Colldén G; Drucker DJ; Feuchtinger A; Caceres CG; Grandl G; Harger A; Herzig S; Hofmann S; Holleman CL; Jastroch M; Keipert S; Kleinert M; Knerr PJ; Kulaj K; Legutko B; Lickert H; Liu X; Luippold G; Lutter D; Malogajski E; Medina MT; Mowery SA; Blutke A; Perez-Tilve D; Salinno C; Sehrer L; DiMarchi RD; Tschöp MH; Stemmer K; Finan B; Wolfrum C; Müller TD
Cell Metab; 2021 Apr; 33(4):833-844.e5. PubMed ID: 33571454
[TBL] [Abstract][Full Text] [Related]
14. GLP-1 receptor signaling is not required for reduced body weight after RYGB in rodents.
Ye J; Hao Z; Mumphrey MB; Townsend RL; Patterson LM; Stylopoulos N; Münzberg H; Morrison CD; Drucker DJ; Berthoud HR
Am J Physiol Regul Integr Comp Physiol; 2014 Mar; 306(5):R352-62. PubMed ID: 24430883
[TBL] [Abstract][Full Text] [Related]
15. Food intake in lean and obese mice after peripheral administration of glucagon-like peptide 2.
Baldassano S; Bellanca AL; Serio R; Mulè F
J Endocrinol; 2012 Jun; 213(3):277-84. PubMed ID: 22457516
[TBL] [Abstract][Full Text] [Related]
16. Central GLP-1 receptor signalling accelerates plasma clearance of triacylglycerol and glucose by activating brown adipose tissue in mice.
Kooijman S; Wang Y; Parlevliet ET; Boon MR; Edelschaap D; Snaterse G; Pijl H; Romijn JA; Rensen PC
Diabetologia; 2015 Nov; 58(11):2637-46. PubMed ID: 26254578
[TBL] [Abstract][Full Text] [Related]
17. Contribution of brown adipose tissue activity to the control of energy balance by GLP-1 receptor signalling in mice.
Heppner KM; Marks S; Holland J; Ottaway N; Smiley D; Dimarchi R; Perez-Tilve D
Diabetologia; 2015 Sep; 58(9):2124-32. PubMed ID: 26049402
[TBL] [Abstract][Full Text] [Related]
18. Robust anti-obesity and metabolic effects of a dual GLP-1/glucagon receptor peptide agonist in rodents and non-human primates.
Henderson SJ; Konkar A; Hornigold DC; Trevaskis JL; Jackson R; Fritsch Fredin M; Jansson-Löfmark R; Naylor J; Rossi A; Bednarek MA; Bhagroo N; Salari H; Will S; Oldham S; Hansen G; Feigh M; Klein T; Grimsby J; Maguire S; Jermutus L; Rondinone CM; Coghlan MP
Diabetes Obes Metab; 2016 Dec; 18(12):1176-1190. PubMed ID: 27377054
[TBL] [Abstract][Full Text] [Related]
19. Central glucagon-like peptide 1 receptor-induced anorexia requires glucose metabolism-mediated suppression of AMPK and is impaired by central fructose.
Burmeister MA; Ayala J; Drucker DJ; Ayala JE
Am J Physiol Endocrinol Metab; 2013 Apr; 304(7):E677-85. PubMed ID: 23341495
[TBL] [Abstract][Full Text] [Related]
20. Glucagon-like peptide-1 receptor in the brain: role in neuroendocrine control of energy metabolism and treatment target for obesity.
Lockie SH
J Neuroendocrinol; 2013 Jul; 25(7):597-604. PubMed ID: 23590331
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
